RhumbLine Advisers’s Contineum Therapeutics CTNM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,573	Closed	-$52.9K	–	4290
2025 Q1	$52.9K	Sell	7,573 -660	-8%	-$4.61K	﹤0.01%	3560
2024 Q4	$121K	Buy	8,233 +2,191	+36%	+$32.1K	﹤0.01%	3420
2024 Q3	$116K	Sell	6,042 -680	-10%	-$13K	﹤0.01%	3460
2024 Q2	$118K	Buy	+6,722	New	+$118K	﹤0.01%	3465